{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"large-cell-immunoblastic-lymphoma","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Malignant lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, one or more prominent nucleoli, and abundant cytoplasm. This class may be subdivided into plasmacytoid and clear-cell types based on cytoplasmic characteristics. A third category, pleomorphous, may be analogous to some of the peripheral T-cell lymphomas (LYMPHOMA, T-CELL, PERIPHERAL) recorded in both the United States and Japan.","mondoId":"MONDO:0022037","node":{"canonicalSlug":"large-cell-immunoblastic-lymphoma","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"large-cell immunoblastic lymphoma","paragraphs":["Malignant lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, one or more prominent nucleoli, and abundant cytoplasm. This class may be subdivided into plasmacytoid and clear-cell types based on cytoplasmic characteristics. A third category, pleomorphous, may be analogous to some of the peripheral T-cell lymphomas (LYMPHOMA, T-CELL, PERIPHERAL) recorded in both the United States and Japan."],"scope":"exact","source":"MONDO","upstream":"MESH:D016400","url":"https://monarchinitiative.org/MONDO:0022037"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"non-Hodgkin lymphoma","mondoId":"MONDO:0018908","slug":"non-hodgkin-lymphoma"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Description attribution is outside exact node scope","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/8219"}],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0022037\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>MESH:D016400</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Malignant lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, one or more prominent nucleoli, and abundant cytoplasm. This class may be subdivided into plasmacytoid and clear-cell types based on cytoplasmic characteristics. A third category, pleomorphous, may be analogous to some of the peripheral T-cell lymphomas (LYMPHOMA, T-CELL, PERIPHERAL) recorded in both the United States and Japan.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0022037\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"large-cell-immunoblastic-lymphoma","sourceDocuments":[{"name":"MONDO: large-cell immunoblastic lymphoma","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0022037"}],"sourceNote":"","synonyms":["Diffuse Immunoblastic Lymphosarcoma","Diffuse Immunoblastic Lymphosarcomas","Diffuse non-Hodgkin lymphoma, immunoblastic","Diffuse non-Hodgkin's immunoblastic (diffuse) lymphoma","Diffuse non-Hodgkin's lymphoma, immunoblastic","Diffuse non-Hodgkin's lymphoma, immunoblastic (clinical)","Immunoblastic Large Cell Lymphoma","IMMUNOBLASTIC LARGE LYMPHOMA","Immunoblastic Large-Cell Lymphoma","Immunoblastic Large-Cell Lymphomas","Immunoblastic Lymphoma, Large-Cell","Immunoblastic Lymphomas, Large-Cell","Immunoblastic Lymphosarcoma, Diffuse","Immunoblastic Lymphosarcomas, Diffuse","Immunoblastic malignant lymphoma - large cell","Immunoblastic Sarcoma","Immunoblastic Sarcomas","Immunoblastoma","Immunoblastomas","Large Cell Immunoblastic Lymphoma","Large cell immunoblastic lymphoma","LARGE IMMUNOBLASTIC LYMPHOMA","Large-Cell Immunoblastic Lymphomas","Large-Cell Lymphoma, Immunoblastic","Large-Cell Lymphomas, Immunoblastic","LYMPHOMA IMMUNOBLASTIC LARGE","LYMPHOMA LARGE IMMUNOBLASTIC","Lymphoma, Immunoblastic Large-Cell","Lymphoma, immunoblastic, high grade","Lymphoma, Immunoblastic, Large Cell","Lymphoma, Immunoblastic, Large-Cell","Lymphoma, Large Cell, Immunoblastic","Lymphoma, Large-Cell Immunoblastic","Lymphoma, Large-Cell, Immunoblastic","Lymphomas, Immunoblastic Large-Cell","Lymphomas, Large-Cell Immunoblastic","Lymphosarcoma, Diffuse Immunoblastic","Lymphosarcomas, Diffuse Immunoblastic","Malignant lymphoma - immunoblastic","Sarcoma, Immunoblastic","Sarcomas, Immunoblastic"],"takeawayHtml":"","title":"large-cell immunoblastic lymphoma"},"schemaVersion":1}
